Accelerate Diagnostic Innovation & Improve Patient Care Outcomes.
A groundbreaking symposium at the 100th annual ASCP conference in 2022. This symposium explored the risks and rewards of mobile phlebotomy for diagnostic providers and prescribers, and its impacts on diagnostic innovation, and healthcare delivery during the COVID-19 pandemic and beyond.
The legalities, compliance issues, and performance of the on-demand economy model meets healthcare delivery and the impact on patient care outcomes were discussed. The symposium addressed how community outreach mobile phlebotomy programs can facilitate better diagnostic utilization, improve patient care outcomes, support advances in bioscience, and liberate diagnostic innovation from its brick and mortar bond holders.
If you want to better understand what a legally compliant mobile phlebotomy program looks like and how it can transform healthcare delivery, this symposium provides essential insights from industry leaders at the intersection of diagnostics, compliance, and patient-centered care.